Cytarabine and Myelitis - a phase IV clinical study of FDA data

Summary:

Myelitis is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Methotrexate, and have Rhabdomyosarcoma.

The phase IV clinical study analyzes which people have Myelitis when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Myelitis?

Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system) is found to be associated with 186 drugs and 340 conditions by eHealthMe. Check the latest studies of Myelitis.

On Jul, 13, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 60 people (0.09%) have Myelitis.

Among these 60 people:

How long have people been on Cytarabine when they have Myelitis? *

What is the gender of people who have Myelitis when taking Cytarabine? *

female: 62 %
male: 38 %

What is the age of people who have Myelitis when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Myelitis? *

Paraplegia (paralysis of the legs and lower body): 15 people, 25.00%
Fever: 5 people, 8.33%
Weakness: 4 people, 6.67%
Myelopathy (any neurologic deficit related to the spinal cord): 4 people, 6.67%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 4 people, 6.67%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 6.67%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 4 people, 6.67%
Confusion: 3 people, 5.00%
Peripheral Motor Neuropathy (muscles in the body become progressively weaker over months to years): 3 people, 5.00%
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 3 people, 5.00%

What are the existing conditions these people have? *

Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 6 people, 10.00%
Neoplasm Malignant (cancer tumour): 5 people, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 8.33%
Precursor T-Lymphoblastic Lymphoma/leukaemia (precursor b-cell cancer): 4 people, 6.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 6.67%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 5.00%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 5.00%
Extra-Osseous Ewing's Sarcoma (primary bone cancer): 3 people, 5.00%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 3.33%
Burkitt's Leukaemia (blood cancer): 2 people, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Myelitis?

- Check whether Myelitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Myelitis treatments and more:

Myelitis (2,018 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myelitis:

Myelitis (186 drugs)

Browse all the conditions that are associated with Myelitis:

Myelitis (340 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.